Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AGIO Agios Pharmaceuticals, Inc.

休市中 05-31 16:00:00 EDT

36.34

-1.20

-3.20%

盘后36.34

+0.000.00%

18:32 EDT

最高38.33	最低36.14	成交量93.31万
今开37.69	昨收37.54	日振幅5.83%
总市值20.63亿	流通市值17.23亿	总股本5,677万
成交额3,435万	换手率1.97%	流通股本4,741万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals, Inc.","latestPrice":36.34,"timestamp":1717185600000,"preClose":37.54,"halted":0,"volume":933084,"hourTrading":{"tag":"盘后","latestPrice":36.34,"preClose":36.34,"latestTime":"18:32 EDT","volume":113953,"amount":4141067.542,"timestamp":1717194725546},"delay":0,"floatShares":47410729,"shares":56772966,"eps":-6.304535,"marketStatus":"休市中","marketStatusCode":7,"change":-1.2,"latestTime":"05-31 16:00:00 EDT","open":37.69,"high":38.33,"low":36.14,"amount":34353789.378228,"amplitude":0.058338,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.304535,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1717401600000},"adr":0,"listingDate":1374638400000,"adjPreClose":37.54,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":36.34,"preClose":36.34,"latestTime":"18:32 EDT","volume":113953,"amount":4141067.542,"timestamp":1717194725546},"volumeRatio":0.7174804171016226},"requestUrl":"/m/hq/s/AGIO/","defaultTab":"news","newsList":[{"id":"2439590147","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590147","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2439590147?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":"    路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括欧特克、麦科森和微策略。要闻  * 模拟器件公司  ：雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc   ：贝尔德将目标价从296美元下调至289美元 * Cencora Inc   ：贝雅将目标价从277美元上调至280美元 * McKesson Corp   ：贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc   ：Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2439590142","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590142","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2439590142?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":"    路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括欧特克、麦科森和微策略。要闻  * 模拟器件公司  ：雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc   ：贝尔德将目标价从296美元下调至289美元 * Cencora Inc   ：贝雅将目标价从277美元上调至280美元 * McKesson Corp   ：贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc   ：Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2438374075","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大涨21.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438374075","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2438374075?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:32","pubTimestamp":1716903122,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时32分，Agios Pharmaceuticals, Inc.股票出现异动，股价大幅拉升21.44%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Exicure, Inc.涨幅较大，Exicure, Inc.、Nls Pharmaceutics Ltd.、Jaguar Health, Inc.较为活跃，换手率分别为18.89%、7.41%、7.09%，振幅较大的相关个股有Exicure, Inc.、Corcept医疗、Sensei Biotherapeutics, Inc.，振幅分别为20.73%、13.15%、10.20%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213202956f167f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213202956f167f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2438751153","title":"BUZZ-与 Royalty Pharma 达成 9.05 亿美元脑肿瘤治疗协议，Agios 公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2438751153","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2438751153?lang=zh_cn&edition=full","pubTime":"2024-05-28 20:20","pubTimestamp":1716898843,"startTime":"0","endTime":"0","summary":"    5月28日 - ** 药物开发商Agios Pharmaceuticals   股价盘前上涨22.2%至38.50美元** 法国药物开发商Servier的脑肿瘤治疗药物vorasidenib获得FDA批准后，该公司将获得11亿美元的付款** 公司计划在美国 FDA 批准 vorasidenib 后，以 9.05 亿美元的预付款将其在美国潜在净销售额中 15% 的版税权出售给 Royalty Pharma    公司， 。** RPRX 从学术实验室和生物技术公司购买未来药物的特许权使用费，这些实验室和生物技术公司用这笔现金资助研究。** AGIO 将保留该疗法在美国年净销售额超过 10 亿美元的 3% 的特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2438729064","title":"Agios Pharmaceuticals, Inc.盘中异动 大幅跳水5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438729064","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2438729064?lang=zh_cn&edition=full","pubTime":"2024-05-25 02:45","pubTimestamp":1716576303,"startTime":"0","endTime":"0","summary":"北京时间2024年05月25日02时45分，Agios Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.17%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Merus N.V.涨幅较大，Onconetix, Inc.、Verastem, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为156.90%、66.95%、37.24%，振幅较大的相关个股有Onconetix, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cns Pharmaceuticals, Inc.，振幅分别为104.53%、57.38%、55.25%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405250245039680fab1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405250245039680fab1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434502869","title":"Agios Pharmaceuticals, Inc.2024财年第一财季实现净利润-81.55百万美元，同比减少0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434502869","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434502869?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:19","pubTimestamp":1715357945,"startTime":"0","endTime":"0","summary":"3月31日，Agios Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为-81.55百万美元，同比减少0.65%；其中营业收入为8.19百万美元，同比增加45.99%，每股基本收益为-1.45美元。机构评级：截至2024年3月31日，当前有6家机构对Agios Pharmaceuticals, Inc.目标价做出预测，其中目标均价为41.67美元，其中最低目标价为30.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110019128af1a7a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110019128af1a7a9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432935222","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432935222","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432935222?lang=zh_cn&edition=full","pubTime":"2024-05-03 01:34","pubTimestamp":1714671295,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日01时34分，Agios Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.02%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Effector Therapeutics Inc C/Wts 31/12/2025 、Sensei Biotherapeutics, Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为4436.56%、676.13%、153.78%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为160.58%、78.82%、49.56%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503013455861eab93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503013455861eab93&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432985868","title":"Agios 制药公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432985868","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432985868?lang=zh_cn&edition=full","pubTime":"2024-05-02 23:08","pubTimestamp":1714662497,"startTime":"0","endTime":"0","summary":"   * Agios Pharmaceuticals Inc   报告了截至3月底的季度调整后每股亏损1.45美元，高于去年同期的每股亏损1.47美元。9位分析师对该季度的平均预期是每股亏损1.65美元。华尔街预期为每股亏损 1.78 美元至 1.53 美元。* 营收同比增长 46%，达到 819 万美元；分析师预期为 837 万美元。* Agios Pharmaceuticals Inc公布的本季度每股收益为亏损1.45美元。* 该公司一季度亏损 8155 万美元。* Agios Pharmaceuticals Inc 的股价本季度上涨了 15.1%，今年迄今为止上涨了 51.1%。华尔街对 Agios Pharmaceuticals Inc 的 12 个月目标价中位数为 45.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432663366","title":"Agios Pharmaceuticals, Inc.盘中异动 急速上涨5.08%报34.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432663366","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432663366?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:47","pubTimestamp":1714589260,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时47分，Agios Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.08%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.93%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Bioatla, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1407.75%、1167.98%、262.29%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020247407925a4c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020247407925a4c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431327730","title":"Agios Pharmaceuticals Inc    预计每股亏损 1.65 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431327730","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431327730?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:36","pubTimestamp":1714487800,"startTime":"0","endTime":"0","summary":"   * Agios Pharmaceuticals Inc    将于5月2日公布截至2024年3月31日的财报，预计季度收入将有所增长。* LSEG 分析师对 Agios Pharmaceuticals Inc 的平均预期是每股亏损 1.65 美元。* 华尔街对 Agios Pharmaceuticals Inc 的 12 个月目标价中位数为 45.00 美元，高于其上次收盘价 32.76 美元。4月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429114352","title":"Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.00%报31.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429114352","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429114352?lang=zh_cn&edition=full","pubTime":"2024-04-24 01:08","pubTimestamp":1713892085,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日01时08分，Agios Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.00%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为2608.87%、180.30%、50.88%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Palisade Bio, Inc.，振幅分别为80.08%、56.09%、45.43%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240108057922b712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240108057922b712&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427759030","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427759030","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427759030?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:40","pubTimestamp":1712947253,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日02时40分，Agios Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.16%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.54%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3675.52%、1450.47%、102.76%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为93.97%、73.57%、58.59%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413024054861e55f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413024054861e55f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426811386","title":"Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426811386","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426811386?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:27","pubTimestamp":1712672823,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时27分，Agios Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.42%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。该信息摘要如下：坎托菲茨杰拉德公司：重申Agios Pharmaceuticals增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040922270487e7ee45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040922270487e7ee45&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426589199","title":"坎托菲茨杰拉德公司：重申Agios Pharmaceuticals(AGIO.US)增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426589199","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426589199?lang=zh_cn&edition=full","pubTime":"2024-04-09 20:36","pubTimestamp":1712666183,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Agios Pharmaceuticals(AGIO.US)增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409203625875a043c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409203625875a043c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414388788","title":"Agios Pharmaceuticals Inc盘中异动 快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414388788","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414388788?lang=zh_cn&edition=full","pubTime":"2024-02-28 01:23","pubTimestamp":1709054607,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日01时23分，Agios Pharmaceuticals Inc股票出现波动，股价急速上涨5.05%。Agios Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Janux Therapeutics Inc、Viking Therapeutics Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃，换手率分别为359.34%、198.03%、38.99%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Janux Therapeutics Inc、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为169.78%、104.30%、75.00%。Agios Pharmaceuticals Inc公司简介：Agios Pharmaceuticals Inc是一家生物制药公司，致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280123277a475931&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280123277a475931&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413767766","title":"Agios Pharmaceuticals Inc盘中异动 早盘股价大涨5.07%报31.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413767766","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413767766?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:57","pubTimestamp":1708700243,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时57分，Agios Pharmaceuticals Inc股票出现波动，股价大幅拉升5.07%。截至发稿，该股报31.29美元/股，成交量14.9166万股，换手率0.27%，振幅4.57%。Agios Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为1.04%。Agios Pharmaceuticals Inc公司简介：Agios Pharmaceuticals Inc是一家生物制药公司，致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322572387e72b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322572387e72b0b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413273894","title":"美国研究综述-Biomarin Pharmaceutical、Intuit、Penumbra","url":"https://stock-news.laohu8.com/highlight/detail?id=2413273894","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413273894?lang=zh_cn&edition=full","pubTime":"2024-02-23 15:28","pubTimestamp":1708673314,"startTime":"0","endTime":"0","summary":"    路透社2月23日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Biomarin Pharmaceutical、Intuit 和 Penumbra。要闻             * Biomarin Pharmaceutical Inc   ：Piper Sandler将目标价从115美元下调至107美元             * Intuit Inc   ：Susquehanna将目标价从700美元上调至775美元             * Penumbra Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413210769","title":"Agios Pharmaceuticals Inc盘中异动 股价大涨5.30%报28.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413210769","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413210769?lang=zh_cn&edition=full","pubTime":"2024-02-22 23:29","pubTimestamp":1708615766,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日23时29分，Agios Pharmaceuticals Inc股票出现波动，股价大幅拉升5.30%。截至发稿，该股报28.22美元/股，成交量10.4536万股，换手率0.19%，振幅5.52%。Agios Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.78%。Agios Pharmaceuticals Inc公司简介：Agios Pharmaceuticals Inc是一家生物制药公司，致力于开发针对癌症和罕见代谢遗传疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222232927791384ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240222232927791384ec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411686106","title":"美国研究综述-阿尔伯马尔、Dropbox、英伟达","url":"https://stock-news.laohu8.com/highlight/detail?id=2411686106","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411686106?lang=zh_cn&edition=full","pubTime":"2024-02-16 21:53","pubTimestamp":1708091615,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Nvidia。要闻 * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Bloom Energy Corp   ：KeyBanc将其评级从 \"增持 \"下调至 \"行业权重\"。* Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp   ：奥本海默将目标价从650美元上调至850美元  * Tyler Technologies Inc   ：Piper Sandler将目标价从480美元上调至520美元  以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agios.com","stockEarnings":[{"period":"1week","weight":0.1537},{"period":"1month","weight":0.0796},{"period":"3month","weight":0.1261},{"period":"6month","weight":0.5869},{"period":"1year","weight":0.4135},{"period":"ytd","weight":0.6318}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.054},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.1487},{"period":"1year","weight":0.2502},{"period":"ytd","weight":0.1095}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Agios Pharmaceuticals, Inc.于2007年8月7日在特拉华州注册成立。该公司是一家生物制药公司，致力于通过细胞代谢领域的领导地位改变患者的生活，目标是为罕见病创造差异化药物，重点是经典血液学。","yearOnYearQuotes":[{"month":1,"riseRate":0.818182,"avgChangeRate":0.042769},{"month":2,"riseRate":0.636364,"avgChangeRate":0.059258},{"month":3,"riseRate":0.545455,"avgChangeRate":0.003251},{"month":4,"riseRate":0.545455,"avgChangeRate":0.006144},{"month":5,"riseRate":0.545455,"avgChangeRate":0.049654},{"month":6,"riseRate":0.6,"avgChangeRate":0.032699},{"month":7,"riseRate":0.3,"avgChangeRate":-0.034242},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.049224},{"month":9,"riseRate":0.545455,"avgChangeRate":0.047807},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.015381},{"month":11,"riseRate":0.636364,"avgChangeRate":0.038309},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.013921}],"exchange":"NASDAQ","name":"Agios Pharmaceuticals, Inc.","nameEN":"Agios Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Agios Pharmaceuticals, Inc.,AGIO,Agios Pharmaceuticals, Inc.股票,Agios Pharmaceuticals, Inc.股票老虎,Agios Pharmaceuticals, Inc.股票老虎国际,Agios Pharmaceuticals, Inc.行情,Agios Pharmaceuticals, Inc.股票行情,Agios Pharmaceuticals, Inc.股价,Agios Pharmaceuticals, Inc.股市,Agios Pharmaceuticals, Inc.股票价格,Agios Pharmaceuticals, Inc.股票交易,Agios Pharmaceuticals, Inc.股票购买,Agios Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}